Conventional and Atypical Deep Penetrating Nevus, Deep Penetrating Nevus-like Melanoma, and Related Variants.

deep penetrating nevus melanocytic lesion melanoma metastatic molecular nevi

Journal

Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988

Informations de publication

Date de publication:
17 Mar 2022
Historique:
received: 20 01 2022
revised: 10 03 2022
accepted: 14 03 2022
entrez: 26 3 2022
pubmed: 27 3 2022
medline: 27 3 2022
Statut: epublish

Résumé

Deep penetrating nevus (DPN) is an uncommon acquired melanocytic lesion with a distinct histopathological appearance that typically behaves in an indolent manner. The lesion is characterized by a symmetrical proliferation of epithelioid to spindled melanocytes associated with abundant melanophages and wedge-shaped extension to the deep reticular dermis and subcutis. Pronounced cytologic atypia and mitotic figures are usually absent, which helps distinguish DPN from melanoma with a deep penetrating growth pattern. Recently, the concept of atypical DPN has been proposed for lesions that demonstrate borderline histomorphologic features and may be associated with lymph node deposits but lack the copy number aberrations typical of melanoma by either fluorescence in situ hybridization or comparative genomic hybridization. While most of these lesions have a favorable clinical course, rare lesions may progress to melanoma. In this review, we summarize the current literature on atypical DPNs with uncertain behavior/metastatic potential and outline the characteristics that distinguish these lesions from conventional DPN and melanoma with DPN-like features.

Identifiants

pubmed: 35336833
pii: biology11030460
doi: 10.3390/biology11030460
pmc: PMC8945163
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Melanoma Research Alliance
ID : Award ID 578728; https://doi.org/10.48050/pc.gr.80580
Pays : United States
Organisme : Institutional Research Grant and Start-up Funding from The University of Texas MD Anderson Cancer Center
ID : IRG
Organisme : NCI NIH HHS
ID : award number P30CA016672, which supports the MD Anderson Cancer Center Clinical Trials Office
Pays : United States

Références

Arch Pathol Lab Med. 2010 Dec;134(12):1770-7
pubmed: 21128774
Arch Dermatol. 2003 Dec;139(12):1608-10
pubmed: 14676079
Am J Surg Pathol. 2020 Oct;44(10):1413-1418
pubmed: 32520758
Virchows Arch. 2019 May;474(5):539-550
pubmed: 30756182
J Cutan Pathol. 1992 Jun;19(3):172-80
pubmed: 1401342
Am J Surg Pathol. 2014 Jun;38(6):824-31
pubmed: 24618603
Pigment Cell Melanoma Res. 2022 Mar;35(2):229-237
pubmed: 34633770
J Am Acad Dermatol. 2008 Sep;59(3):518-23
pubmed: 18640742
Mod Pathol. 2006 Oct;19(10):1378-85
pubmed: 16829852
J Am Acad Dermatol. 1994 May;30(5 Pt 1):724-9
pubmed: 8176011
J Cutan Pathol. 2020 Dec;47(12):1150-1154
pubmed: 32526042
Histopathology. 2003 Dec;43(6):529-37
pubmed: 14636253
Front Oncol. 2020 May 20;10:837
pubmed: 32509588
Arch Pathol Lab Med. 2011 Mar;135(3):321-6
pubmed: 21366455
Histopathology. 1991 Mar;18(3):243-7
pubmed: 2045075
Am J Dermatopathol. 2020 Dec;42(12):948-952
pubmed: 32568834
J Cutan Pathol. 2012 Jan;39(1):25-8
pubmed: 22211333
Am J Surg Pathol. 1989 Jan;13(1):39-44
pubmed: 2909196
Hum Pathol. 1991 Jan;22(1):52-8
pubmed: 1985078
J Am Acad Dermatol. 2014 Dec;71(6):1234-40
pubmed: 25175710
Arch Dermatol. 1993 Mar;129(3):328-31
pubmed: 8447669
Mod Pathol. 2013 Oct;26(10):1320-8
pubmed: 23599145
Ann Diagn Pathol. 2017 Jun;28:30-36
pubmed: 28648937
Am J Dermatopathol. 1991 Dec;13(6):543-50
pubmed: 1725245
J Cutan Pathol. 2012 Jan;39(1):21-4
pubmed: 22211332
J Cutan Pathol. 2021 Apr;48(4):597-600
pubmed: 33094849
Eur J Dermatol. 2014 Sep-Oct;24(5):594-602
pubmed: 25118781
Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2486-90
pubmed: 18006941
Hum Pathol. 2014 Dec;45(12):2369-78
pubmed: 25300464
J Am Acad Dermatol. 2006 Sep;55(3):460-6
pubmed: 16908352
J Am Acad Dermatol. 1995 Oct;33(4):685-7
pubmed: 7545707
J Cutan Pathol. 2017 Mar;44(3):249-255
pubmed: 28032662
Nat Commun. 2017 Sep 21;8(1):644
pubmed: 28935960
Am J Surg Pathol. 2018 Nov;42(11):1456-1465
pubmed: 30045064
Am J Dermatopathol. 2018 Jul;40(7):469-478
pubmed: 29923908
J Cutan Pathol. 2018 Apr;45(4):254-262
pubmed: 29341232
Cancers (Basel). 2021 Jun 19;13(12):
pubmed: 34205480
J Am Acad Dermatol. 2010 Mar;62(3):469-79
pubmed: 20159313
Am J Surg Pathol. 2010 Mar;34(3):314-26
pubmed: 20118771
Pathology. 2004 Oct;36(5):419-27
pubmed: 15370111
Virchows Arch. 2019 May;474(5):535-537
pubmed: 30868296
Histopathology. 2015 Oct;67(4):425-41
pubmed: 24438036
Histopathology. 2021 Sep;79(3):291-305
pubmed: 33772838

Auteurs

Pavandeep Gill (P)

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
Department of Laboratory Medicine, Vancouver Island Health Authority, Victoria, BC V8R 1J8, Canada.

Phyu P Aung (PP)

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Classifications MeSH